BRAFTOVI HARD CAPSULE 50MG Singapore - English - HSA (Health Sciences Authority)

braftovi hard capsule 50mg

pierre fabre singapore pte ltd - encorafenib - capsule - encorafenib 50mg

BRAFTOVI HARD CAPSULE 75MG Singapore - English - HSA (Health Sciences Authority)

braftovi hard capsule 75mg

pierre fabre singapore pte ltd - encorafenib - capsule - encorafenib 75mg

Braftovi European Union - English - EMA (European Medicines Agency)

braftovi

pierre fabre medicament - encorafenib - melanoma; colorectal neoplasms - antineoplastic agents - encorafenib is indicated:in combination with binimetinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutationin combination with cetuximab, for the treatment of adult patients with metastatic colorectal cancer (crc) with a braf v600e mutation, who have received prior systemic therapy

BRAFTOVI CAPSULE Canada - English - Health Canada

braftovi capsule

pfizer canada ulc - encorafenib - capsule - 75mg - encorafenib 75mg - antineoplastic agents